General Information of Drug (ID: DMWE205)

Drug Name
DCR-MYC Drug Info
Indication
Disease Entry ICD 11 Status REF
Hepatocellular carcinoma 2C12.02 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMWE205

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MYCBP messenger RNA (MYCBP mRNA) TTVW4XU MYCBP_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT02314052) Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 759983).